netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

New Report Aims to Make Eye Health a Public Health Priority

Vision impairment leads to major challenges, such as social isolation, depression, and injuries in adults and developmental, academic, and social issues in children. People with lower socioeconomic status and poor health are at even greater risk for negative outcomes related to poor vision. And yet vision impairment is often left out of population health agendas or community programs.

Today, the National Academies of Sciences, Engineering, and Medicine released a report, Making Eye Health a Population Health Imperative: Vision for Tomorrow, that issues nine concrete recommendations for improving eye and vision health and increasing health equity. Research to Prevent Blindness and nine other organizations provided sponsorship for the study, which proposes a much-needed framework to improve eye and vision health for all in the United States, and addresses both correctable and uncorrectable vision impairment. 

The recommendations fall under five key themes:

  • Facilitate Public Awareness through Timely Access to Accurate and Locally Relevant Information;
  • Generate Evidence to Guide Policy Decisions and Evidence-based Action;
  • Expand Access to Appropriate Clinical Care;
  • Enhance Public Health Capacities to Support Vision-Related Activities; and
  • Promote Community Actions that Encourage Eye- and Vision-Healthy Environments.

RPB is committed to generating more and better evidence through the support of grants that allow researchers to target the causes of and potential treatments or cures for vision disorders that can lead to blindness. In the report, Recommendation 4 specifically speaks to the need for such grant programs, led by a common research agenda developed by the U.S. Department of Health and Human Services with public, private, and community involvement.  

Read the Report

Related News: Feature Story

RPB-SUPPORTED RESEARCHERS WILL BE INTEGRAL PART OF LATEST EFFORT WITHIN NEI’S AUDACIOUS GOALS INITIATIVE

Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.

Read More

 

EMERGING VISION SCIENTISTS EDUCATE, THANK CONGRESS FOR RESEARCH APPROPRIATIONS

(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.

Read More

 

RESEARCH TO PREVENT BLINDNESS AND LIONS CLUBS INTERNATIONAL FOUNDATION TO CONTINUE LOW VISION RESEARCH AWARD PARTNERSHIP

Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.

Read More

 

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

Read More

 

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.

Read More

 

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.